UBS analysts project worldwide GLP-1 utilisation to exceed 50 million people by 2030, describing GLP-1s as a structural demand story with no signs of slowing
When retatrutide attaches to this receptor, it boosts the production of glucagon, a hormone that helps break down stored energy like fat and sugar
Equation to estimate body weight in elderly Mexican women using anthropometric measurements
We are dedicated to providing science-forward solutions that prioritize absorption and transparency
2025 GLP-1 Impacts Tell Us About CDMOs In 2026 By Louis Garguilo, Chief Editor, Outsourced Pharma When we began covering the nexus between GLP-1 drugs and CDMO capacity, there were two key questions: Could Novo Nordisk and Eli Lilly (and followers) keep up supply via internal and external manufacturing to meet exponential demand
Do I need to exercise for L-Carnitine to work